Previous 10 | Next 10 |
home / stock / nonof / nonof news
2023-09-03 12:00:00 ET More on Medicare pricing negotiations Wall Street lists potential targets for Medicare drug price negotiations Analysts rule out major industry impact from drug pricing negotiations J&J, Merck, Regeneron most exposed to Medicare drug price ...
2023-09-01 07:54:49 ET More on Novo Nordisk Novo Nordisk: Super Focused Pharma Company For The Long Run Novo Nordisk: Strong Fundamentals Meet Technical Uptrends Eli Lilly And Novo Nordisk: Are Weight Loss Drugs A Global Revolution Or Short-Lived Fad? Novo No...
2023-08-31 11:17:22 ET Summary Novo Nordisk is a high-quality pharmaceutical company with a unique ownership structure, controlled by a charitable foundation. The company specializes in diabetes and obesity treatments, with a focus on insulin and GLP-1 analogues. Despite a tem...
2023-08-30 09:48:11 ET More on Novo Nordisk Novo Nordisk: Market Leader In A Growing Market Novo Nordisk: High Valuation Reflects Promising Outlook In Obesity Care Novo Nordisk: Denmark's Coca-Cola The Case For Novo Nordisk: Growth, Dividends, And A New Treat...
2023-08-29 07:45:20 ET The Centers for Medicare and Medicaid Services (CMS) announced on Tuesday the first 10 Medicare Part D drugs it selected for pricing negotiations, a provision introduced as part of last year's Inflation Reduction Act. The list includes Eliquis , a blood thinne...
2023-08-23 09:00:14 ET More on Novo, Thermo, etc. Thermo Fisher: Cash Flow Returns On Investments Analysis Novo Nordisk A/S 2023 Q2 - Results - Earnings Call Presentation Novo Nordisk A/S ( NVO ) Q2 2023 Earnings Call Transcript Novo Nordisk: Market Leade...
2023-08-18 13:09:45 ET Summary On August 7, Viatris released its financial results for the 2nd quarter of 2023, which, after a long time, finally managed to beat analysts' expectations. Viatris' revenue for the second quarter of 2023 was $3.92 billion, up 5.1% from the previous qu...
2023-08-15 15:06:54 ET Billionaire investor Philippe Laffont's Coatue Management in Q2 2023 took news stakes in Eli Lilly ( NYSE: LLY ) and Oracle ( NYSE: ORCL ), exited GameStop ( NYSE: GME ) and Salesforce ( NYSE: CRM ), trimmed its positions in Tesla ...
2023-08-10 12:03:57 ET More on Novo Nordisk Novo Nordisk A/S ( NVO ) Q2 2023 Earnings Call Transcript Novo Nordisk: High Valuation Reflects Promising Outlook In Obesity Care Novo Nordisk: Denmark's Coca-Cola The Case For Novo Nordisk: Growth, Dividends, A...
2023-08-10 11:41:04 ET Novo Nordisk A/S (NVO) Q2 2023 Earnings Conference Call August 10, 2023, 07:00 ET Company Participants Daniel Bohsen - CVP & Head, IR Lars Jorgensen - President & CEO Camilla Sylvest - EVP, Commercial Strategy & Corporate Affair...
News, Short Squeeze, Breakout and More Instantly...
Partnership will leverage Aspect’s proprietary bioprinting technology and Novo Nordisk’s expertise and technology in stem cell differentiation and cell therapy development and manufacturing . Aspect to receive 75 million US dollars in initial payments and u...
New York City, NY: May 06, 2020 – Published via (Wired Release):- “Market.us presents a new report titled Alkyl Benzyl Dimethyl Ammonium Chloride Market: 2020 Research and New Innovations in Oil and Gas Sector. The prime objective of the report is to offer updates and information...